Create a free research account to view current pricing and place an order.
How does Prostamax work in research models?
Prostate bioregulator peptide researched for prostate tissue-support concepts.
What is the half-life of Prostamax?
Half-life: Not standardized.
Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
Research dosing reference
2-5 mg daily in short-course bioregulator protocols.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 2 mg | 20 units |
| 5 mg | 50 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is Prostamax reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 20 mg | 2 mL BAC Water | 0.100 mg/unit |
Injection timing
Often used in short cycles; consistent daily timing is preferred for interpretation rather than acute-effect timing.
Beginner escalation
Begin at the low end of the cycle exposure and assess tolerance before extending duration or combining with additional bioregulators.
Side-effect mitigation
Monitor injection tolerance, fatigue, headache, sleep changes, mood shifts, or unexpected organ-specific symptoms. Human standardization is limited.
Stack compatibility
Bioregulators can be paired by tissue objective, but introducing one at a time improves interpretability.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Bioregulator protocols are commonly structured as short courses. Reassess after 10-30 days and allow an off-interval before repeating unless a clinician-directed objective supports continuation.
Frequently asked questions
What is Prostamax and how is it studied?
Prostate bioregulator peptide researched for prostate tissue-support concepts. Prostamax is catalogued in the Bioregulators / Organ Support group of this reference and is studied in laboratory and in-vitro models only. Prostamax is listed in this reference for laboratory context only; nothing here describes use in a person or animal.
What is known about the half-life of Prostamax?
Reference half-life for Prostamax: not standardized. Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is Prostamax stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is Prostamax reconstituted for laboratory work?
The reference reconstitution for the 20 mg vial is 2 mL BAC Water, which gives a concentration of about 10 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is Prostamax FDA approved?
No. The research-grade Prostamax described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration